Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon May 27, 2021 4:30pm
492 Views
Post# 33280126

RE:RE:RE:Ridiculous

RE:RE:RE:Ridiculous

Analyst forecasts too negative. Co. earned $0.21 eps on $80 mil revenue in 2019 but analysts think co. will earn only $0.204 on $115.7 mil revenue in 2021.   

 

$US

eps

Revenue

ebitda

2022 (e)

$0.322

133.6M

 

2021 (e)

$0.204

115.7M

 

2020 (a)

$0.78

131.3M

41.3M

2019 (a)

$0.21

80.3M

19.0M

 

 



lscfa wrote:

 

 

$USD

2022 (e)

$0.322

2021 (e)

$0.204

2020 (a)

$0.78

2019 (a)

$0.21

 


 

lscfa wrote: Trailing eps is misleading due to one time Covid boost.    

 

Trytobelong wrote: VMD is trading on ly 12x eps

At this price, we could see a buy out

 




<< Previous
Bullboard Posts
Next >>